Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Devika Agarwal

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Genome Biology|July 8, 2024
Panpipes: a pipeline for multiomic single-cell and spatial transcriptomic data analysisFabiola Curion, Charlotte Rich-Griffin, Devika Agarwal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2015
HAGE in Triple-Negative Breast Cancer Is a Novel Prognostic, Predictive, and Actionable Biomarker: A Transcriptomic and Protein Expression AnalysisTarek M A Abdel-Fatah, Stephanie E B McArdle, Devika Agarwal, et al.
Neoplasia (New York, N.Y.)|November 27, 2014
Clinicopathological significance of ATM-Chk2 expression in sporadic breast cancers: a comprehensive analysis in large cohortsTarek M A Abdel-Fatah, Arvind Arora, Nouf Alsubhi, et al.
Breast Cancer Research and Treatment|February 25, 2016
The prognostic significance of STAT3 in invasive breast cancer: analysis of protein and mRNA expressions in large cohortsMohammed A Aleskandarany, Devika Agarwal, Ola H Negm, et al.
Molecular Cancer Therapeutics|February 13, 2015
Transcriptomic and Protein Expression Analysis Reveals Clinicopathological Significance of Bloom Syndrome Helicase (BLM) in Breast CancerArvind Arora, Tarek M A Abdel-Fatah, Devika Agarwal, et al.
Molecular Oncology|December 4, 2014
Untangling the ATR-CHEK1 network for prognostication, prediction and therapeutic target validation in breast cancerTarek M A Abdel-Fatah, Fiona K Middleton, Arvind Arora, et al.
Molecular Oncology|September 11, 2014
Targeting BRCA1-BER deficient breast cancer by ATM or DNA-PKcs blockade either alone or in combination with cisplatin for personalized therapyNada Albarakati, Tarek M A Abdel-Fatah, Rachel Doherty, et al.
The Lancet. Oncology|June 18, 2016
SPAG5 as a prognostic biomarker and chemotherapy sensitivity predictor in breast cancer: a retrospective, integrated genomic, transcriptomic, and protein analysisTarek M A Abdel-Fatah, Devika Agarwal, Dong-Xu Liu, et al.
The Journal of Pathology|December 23, 2015
RECQL4 helicase has oncogenic potential in sporadic breast cancersArvind Arora, Devika Agarwal, Tarek Ma Abdel-Fatah, et al.
Carcinogenesis|November 21, 2015
Clinicopathological and prognostic significance of RECQL5 helicase expression in breast cancersArvind Arora, Tarek M A Abdel-Fatah, Devika Agarwal, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Genome Biology|July 8, 2024
Panpipes: a pipeline for multiomic single-cell and spatial transcriptomic data analysisFabiola Curion, Charlotte Rich-Griffin, Devika Agarwal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2015
HAGE in Triple-Negative Breast Cancer Is a Novel Prognostic, Predictive, and Actionable Biomarker: A Transcriptomic and Protein Expression AnalysisTarek M A Abdel-Fatah, Stephanie E B McArdle, Devika Agarwal, et al.
Neoplasia (New York, N.Y.)|November 27, 2014
Clinicopathological significance of ATM-Chk2 expression in sporadic breast cancers: a comprehensive analysis in large cohortsTarek M A Abdel-Fatah, Arvind Arora, Nouf Alsubhi, et al.
Breast Cancer Research and Treatment|February 25, 2016
The prognostic significance of STAT3 in invasive breast cancer: analysis of protein and mRNA expressions in large cohortsMohammed A Aleskandarany, Devika Agarwal, Ola H Negm, et al.
Molecular Cancer Therapeutics|February 13, 2015
Transcriptomic and Protein Expression Analysis Reveals Clinicopathological Significance of Bloom Syndrome Helicase (BLM) in Breast CancerArvind Arora, Tarek M A Abdel-Fatah, Devika Agarwal, et al.
Molecular Oncology|December 4, 2014
Untangling the ATR-CHEK1 network for prognostication, prediction and therapeutic target validation in breast cancerTarek M A Abdel-Fatah, Fiona K Middleton, Arvind Arora, et al.
Molecular Oncology|September 11, 2014
Targeting BRCA1-BER deficient breast cancer by ATM or DNA-PKcs blockade either alone or in combination with cisplatin for personalized therapyNada Albarakati, Tarek M A Abdel-Fatah, Rachel Doherty, et al.
The Lancet. Oncology|June 18, 2016
SPAG5 as a prognostic biomarker and chemotherapy sensitivity predictor in breast cancer: a retrospective, integrated genomic, transcriptomic, and protein analysisTarek M A Abdel-Fatah, Devika Agarwal, Dong-Xu Liu, et al.
The Journal of Pathology|December 23, 2015
RECQL4 helicase has oncogenic potential in sporadic breast cancersArvind Arora, Devika Agarwal, Tarek Ma Abdel-Fatah, et al.
Carcinogenesis|November 21, 2015
Clinicopathological and prognostic significance of RECQL5 helicase expression in breast cancersArvind Arora, Tarek M A Abdel-Fatah, Devika Agarwal, et al.
Pageof 4